0000880771-17-000003.txt : 20170105
0000880771-17-000003.hdr.sgml : 20170105
20170105185233
ACCESSION NUMBER: 0000880771-17-000003
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170103
FILED AS OF DATE: 20170105
DATE AS OF CHANGE: 20170105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000880771
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943116852
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 950 TOWER LANE
STREET 2: SUITE 900
CITY: FOSTER CITY
STATE: CA
ZIP: 94404-2125
BUSINESS PHONE: 650-358-3456
MAIL ADDRESS:
STREET 1: 950 TOWER LANE
STREET 2: SUITE 900
CITY: FOSTER CITY
STATE: CA
ZIP: 94404-2125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Blobel Friedhelm
CENTRAL INDEX KEY: 0001363213
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19825
FILM NUMBER: 17512404
MAIL ADDRESS:
STREET 1: 950 TOWER LANE, SUITE 900
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
4
1
certent-form4.xml
PRIMARY DOCUMENT
X0306
4
2017-01-03
0000880771
SCICLONE PHARMACEUTICALS INC
SCLN
0001363213
Blobel Friedhelm
950 TOWER LANE, SUITE 900
FOSTER CITY
CA
94404
1
1
0
0
President & CEO
Common Stock
2017-01-03
4
M
0
300
1.81
A
87084
D
Common Stock
2017-01-03
4
S
0
300
11
D
86784
D
Common Stock
2017-01-04
4
M
0
100
1.81
A
86884
D
Common Stock
2017-01-04
4
S
0
100
11
D
86784
D
Common Stock
2017-01-05
4
M
0
9200
1.81
A
95984
D
Common Stock
2017-01-05
4
S
0
9200
11.0204
D
86784
D
Non-Qualified Stock Option (right to buy)
1.81
2017-01-03
4
M
0
300
0
D
2018-03-18
Common Stock
300
39700
D
Non-Qualified Stock Option (right to buy)
1.81
2017-01-04
4
M
0
100
0
D
2018-03-18
Common Stock
100
39600
D
Non-Qualified Stock Option (right to buy)
1.81
2017-01-05
4
M
0
9200
0
D
2018-03-18
Common Stock
9200
30400
D
The reported sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 18, 2016.
Granted under the Issuer's 2005 Equity Incentive Plan.
1/36th of such shares will vest on June 1, 2010 and 1/36th will vest monthly thereafter over a three-year period, provided the reporting person remains employed by the Company.
/s/ Wilson W. Cheung, Attorney-in-Fact for: Friedhelm Blobel
2017-01-05